Trump plans 100% tariff on drugs, sets implementation date
Translated from Turkish, summarized and contextualized by DistantNews.
At a glance
- U.S. President Donald Trump announced a plan to impose tariffs on generic drugs.
- Tariffs will start at 0% for two years, then rise to 100% for one year, and finally 200% thereafter.
- The policy aims to incentivize drug manufacturing to return to the U.S., with sanctions for companies not investing in domestic factories.
U.S. President Donald Trump has announced a plan to implement significant tariffs on generic drugs, aiming to bring pharmaceutical production back to the United States. The new policy is set to take effect on August 1.
The tariff rate will be applied as 0 percent for a period of two years
According to Trump's social media announcement, the tariff rate for all generic drugs imported into the U.S. will remain at 0% for an initial two-year period. Following this period, the tariff rate will increase to 100% for one year, and subsequently to 200% thereafter.
sanctions will be applied to companies that do not prefer to invest in factories and equipment within the specified period
Trump stated that the primary goal of this policy is to encourage the domestic production of generic drugs. Companies that do not choose to invest in factories and equipment within the specified timeframe will face sanctions. He asserted that the policy's objective is to "protect the American people."
The aim of the policy is to 'protect the American people'
The president also clarified that the existing policy for patented, branded, or innovative drugs will remain unchanged. He noted a significant increase in the construction of drug manufacturing facilities across the U.S., describing it as an unprecedented level.
drug manufacturing facilities are being built across the United States at a level never seen before
Originally published by Cumhuriyet in Turkish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.